Skip to Main Content

Try STAT+ TODAY

Uncategorized

Most Read

Politics Tracy Jan — Boston Globe

Surgery that launched Ben Carson’s fame ended poorly for twins

Ryan Cross — The Boston Globe

STAT Plus: Takeda autoimmune therapy shows effectiveness in key trial

Health John Gregory

Health websites are notoriously misleading. So we rated their reliability

STAT

STAT Madness Application

Don't Miss Eric Boodman

Night sweats, bloody cough — and a diagnosis that turned a doctor into an activist

Politics Leah Samuel

STAT Plus: After a long career pushing the boundaries, Joycelyn Elders pushes for racial equality in medicine

Evan Allen — Boston Globe and David Armstrong — STAT

Addiction treatment center’s admissions shut down by Mass. over safety concerns

John W. Henry

Why I started STAT

All Coverage

STAT

Targeting cancer: the new frontier of immunotherapy and precision oncology

Health Isabella Cueto

STAT Plus: Following your gut: How scientists are getting closer to linking the microbiome and chronic diseases

advertisement

Zeke Miller and Chris Megerian — Associated Press

STAT Plus: Biden pardons thousands for possession of marijuana and moves toward reclassification

In the Lab Isabella Cueto

When spinal fluid from ALS patients was put into mice, the mice got weak. An unlikely protein could be the culprit

Pharmalot Ed Silverman

STAT Plus: Lawmakers ask GAO to probe pharmacy benefit managers over their role in drug pricing

STAT

The need for speed and safety: A primer on the FDA’s drug approval pathways

Katie Palmer, Casey Ross and Mohana Ravindranath

A machine learning company pitches its plan to get ahead of the next pandemic

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Congress wants opioid settlement tax breaks probed; Another yawner of a drug pricing hearing?

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Insurers balk at opioid payouts to drugmakers and wholesalers; AbbVie settles another Humira biosimilar lawsuit

Casey Ross and Katie Palmer

How to train a clinical AI to predict bad health outcomes

Don't Miss STAT Staff

STAT Plus: A preview of the burning biotech and health tech questions at JPM 2022

STAT

Continuous glucose monitoring: how it’s advancing diabetes care

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Biogen cuts price of Alzheimer’s drug in half and plans cost cuts; Moderna test suggests booster works against Omicron

STAT

The ‘shroom boom’: The meteoric rise of the psychedelic medicine industry

Jeremy C. Fox — Boston Globe

STAT Plus: MIT professor sues after he was forced to resign from institute following sexual harassment allegations

Jonathan Saltzman — Boston Globe

STAT Plus: Lawyers for Henrietta Lacks estate say more companies to be sued over use of her cells

STAT Staff

Who telehealth isn’t reaching & Apple looks past A-fib

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: CDC director overrules panel and recommends Pfizer shot for at-risk workers; DOD watchdog faults military over pharma supply chain issues

STAT

2021 Update: Ranking biotech’s top venture capital firms

STAT Staff

A first-of-its-kind bet for an Alphabet spinout

STAT Staff

Isabella Cueto named the first Sharon Begley-STAT Science Reporting fellow

STAT

Understanding synthetic biology, featuring 10 companies to watch

STAT

Nanotechnology in Medicine

STAT Staff

Good bacteria: The microbiome, its vast therapeutic potential, and the challenges ahead

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Biden aides met with U.S. health companies about supply chains; J&J Covid-19 shot notched $100m in sales